Has the time for first-line treatment with second generation tyrosine kinase inhibitors in patients with chronic myelogenous leukemia already come? Systematic review and meta-analysis

  • Ronit Gurion
  • , Anat Gafter-Gvili
  • , Liat Vidal
  • , Avi Leader
  • , Ron Ram
  • , Adi Shacham-Abulafia
  • , Mical Paul
  • , Isaac Ben-Bassat
  • , Ofer Shpilberg
  • , Pia Raanani

Research output: Contribution to journal › Review article › peer-review

27 Scopus citations

Fingerprint

Dive into the research topics of 'Has the time for first-line treatment with second generation tyrosine kinase inhibitors in patients with chronic myelogenous leukemia already come? Systematic review and meta-analysis'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science